Optical Coherence Pachymetry to Evaluate Central Corneal Ablation Depth in Myopic Femtosecond Laser in Situ Keratomileusis
PACO
Optical Coherence Pachymetry (OCP) to Evaluate Central Corneal Ablation Depth in Myopic Femtosecond Laser in Situ Keratomileusis (LASIK)
1 other identifier
observational
50
1 country
1
Brief Summary
Prospective study aiming to measure central ablation depth during excimer laser surgery in myopic patients operated with femtosecond laser assisted LASIK with intraoperative OCP, before and after laser ablation. This measurement will be compared with pre and 1 month postoperative topography differential pachymetric measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 26, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2016
CompletedFirst Submitted
Initial submission to the registry
August 30, 2016
CompletedFirst Posted
Study publicly available on registry
September 8, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2017
CompletedMarch 20, 2017
March 1, 2017
2.2 years
August 30, 2016
March 17, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
depth of central corneal ablation
measured in microns with OCP
1 month after surgery
Eligibility Criteria
patients undergoing refractive surgery with LASIK
You may qualify if:
- Patients over 18 years old
- undergoing refractive surgery with LASIK
- with myopic or compound myopic astigmatism ametropia
- without irregular cornea and topographical sign of keratoconus
- preoperative corneal thickness compatible with LASIK
You may not qualify if:
- hyperopia
- opposition to participate in the study
- no health insurance coverage
- patient under legal protection
- pregnant or breastfeeding patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SALOMON
Paris, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Luc FEBBRARO, MD
Fondation OPH A de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2016
First Posted
September 8, 2016
Study Start
May 26, 2014
Primary Completion
July 26, 2016
Study Completion
March 15, 2017
Last Updated
March 20, 2017
Record last verified: 2017-03